Medicines used to treat aspergillosis can be very important, but they can also be complicated. Carers often help with medication reminders, monitoring side effects, keeping track of blood tests and understanding why treatment changes. This guide explains the main treatments, what monitoring involves and how carers can support safe medicine use.
Key Points
- Different forms of aspergillosis require different treatments. Some people need antifungal medicines, others need treatment for allergic inflammation, and some need both.
- Treatment may take time to work and sometimes aims to control a long-term condition rather than provide a quick cure.
- Antifungal medicines can interact with other treatments, including certain inhaled steroids.
- Blood tests and other monitoring help ensure treatment remains safe and effective.
- Steroid treatment should not be stopped suddenly without medical advice.
- Carers can help by keeping accurate medicine records, recognising possible side effects and supporting communication with the clinical team.
Contents
- Why Medicines Matter in Aspergillosis
- Main Types of Treatment
- Antifungal Medicines
- Steroids and Anti-inflammatory Treatment
- Biologic Treatments
- Why Monitoring and Blood Tests Matter
- Recognising Possible Side Effects
- Understanding Drug Interactions
- How Carers Can Help Safely
- When to Seek Medical Advice
- Further Information
Why Medicines Matter in Aspergillosis
Aspergillosis is not one single illness. Treatment depends on the type of disease, its severity and the person’s wider health.
Some people need medicines to control fungal infection. Others need treatment to reduce allergic inflammation. Some require a combination of treatments.
Decisions may also be influenced by conditions such as asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), kidney or liver problems, and other medicines the person takes.
For carers, an important point to understand is that treatment often involves balancing the expected benefits against possible side effects and interactions.
A medicine that works well for one person may not be suitable for another.
Main Types of Treatment
Medicines used in the management of aspergillosis and associated lung conditions may include:
- Antifungal medicines: Reduce fungal growth or activity.
- Corticosteroids: Reduce inflammation, particularly in allergic forms of aspergillosis.
- Biologic medicines: Target particular immune pathways in selected patients with severe asthma or allergic disease.
- Supportive treatments: May include inhalers, antibiotics and medicines for other lung conditions.
Not everyone needs all these treatments. Some people may not need antifungal treatment at all, while others require prolonged courses or changes between medicines.
Antifungal Medicines
Antifungal medicines are used when treatment aims to control fungal growth or infection. They are particularly important in conditions such as chronic pulmonary aspergillosis (CPA), invasive aspergillosis and some cases of Aspergillus bronchitis.
Antifungals may also be used in selected patients with allergic bronchopulmonary aspergillosis (ABPA).
Common oral antifungal medicines include:
- Itraconazole
- Voriconazole
- Posaconazole
- Isavuconazole
Other antifungal medicines, including intravenous treatments, may be used in particular circumstances.
Why treatment can take time
Antifungal medicines do not always produce an immediate improvement. In chronic infections, it may take weeks or months to assess the full response.
Doctors consider symptoms, blood tests, scans and other investigations when deciding whether treatment is working.
A change of antifungal does not necessarily mean that treatment has failed. Sometimes a different medicine is chosen because of side effects, drug interactions, resistance or difficulties achieving adequate drug exposure.
Why antifungal blood levels matter
Some antifungal medicines are absorbed or processed differently from person to person. Measuring the amount of medicine in the blood is called therapeutic drug monitoring (TDM).
TDM is routinely used for itraconazole, voriconazole and posaconazole in many clinical settings. Routine TDM is not generally required for isavuconazole, although it may be considered in particular circumstances.
Blood tests may also be needed to monitor liver function and other potential treatment effects.
Carers can help by keeping track of blood test appointments and checking that the patient knows how and when to take their medicine. Some antifungals have specific instructions about food, timing or other medicines.
Steroids and Anti-inflammatory Treatment
In allergic forms of aspergillosis, particularly ABPA, much of the illness is caused by an excessive immune response to Aspergillus.
Corticosteroids, such as prednisolone, can reduce this inflammation and may improve symptoms.
However, steroids can also cause side effects, especially at higher doses or when used for prolonged periods.
Carers may notice:
- Mood changes or irritability
- Difficulty sleeping
- Increased appetite or weight gain
- Raised blood sugar
- Muscle weakness
- Increased susceptibility to infections
- Changes in skin or bone health with longer-term treatment
These effects can influence everyday life and relationships. Sometimes changes in mood or sleep are caused partly by the treatment rather than the illness itself.
Why steroids must not be stopped suddenly
Long-term steroid treatment can suppress the adrenal glands, reducing the body’s ability to produce its own cortisol.
Stopping steroids abruptly, or reducing the dose too quickly, can cause serious problems in someone whose adrenal function has been suppressed.
Important: Patients should not stop or change steroid treatment without medical advice. Anyone with known adrenal insufficiency should follow their individual steroid replacement and sick-day instructions.
Antifungals and inhaled steroids
Some azole antifungal medicines can increase exposure to certain corticosteroids, including inhaled or nasal steroids. This can increase the risk of steroid side effects and adrenal suppression.
Clinicians and pharmacists should review these combinations carefully. Carers can help by ensuring that inhalers, nasal sprays, creams and tablets are all included on the patient’s medicine list.
Biologic Treatments
Some people with severe asthma, allergic inflammation or ABPA may be offered biologic medicines.
These treatments target particular parts of the immune system involved in inflammation.
Examples used for severe asthma and, in selected circumstances, ABPA include omalizumab, mepolizumab, benralizumab, dupilumab and tezepelumab.
Their suitability depends on the individual patient’s condition, eligibility and specialist assessment. Not all biologics are specifically licensed for ABPA.
Biologic treatments may help improve asthma control, reduce exacerbations or reduce the need for oral steroids in suitable patients.
Carers may find it useful to understand:
- Why a particular biologic has been recommended
- How the clinical team will assess whether it is helping
- Whether injections are given at home or in a clinic
- Which side effects should be reported
- Whether other treatments need to continue
Biologics do not automatically replace antifungal medicines or other prescribed treatments.
Why Monitoring and Blood Tests Matter
Monitoring is an important part of aspergillosis treatment. It helps clinicians check both whether a medicine is effective and whether it is causing unwanted effects.
Depending on the treatment, monitoring may include:
- Antifungal blood levels
- Liver function tests
- Kidney function and electrolyte tests
- Blood counts or blood sugar measurements
- Assessment of possible steroid side effects
- ECG monitoring for medicines that may affect heart rhythm
- Lung function tests, imaging or other assessments of disease activity
Not every patient needs every test. The monitoring schedule depends on the medicine, other health conditions and the treating team’s recommendations.
Regular blood tests do not necessarily mean something is wrong. They are often a routine part of keeping treatment safe.
Carers can help by keeping a calendar of appointments and encouraging the patient to ask about results that have not been communicated.
Recognising Possible Side Effects
Side effects vary between medicines and between individuals. Some are mild and temporary, while others require treatment changes or prompt assessment.
Possible symptoms include:
- Nausea, abdominal discomfort or poor appetite
- Unusual tiredness or weakness
- Changes in sleep or mood
- Skin rashes or increased sensitivity to sunlight
- Visual disturbances with certain antifungal medicines
- Dizziness, tingling or other neurological symptoms
- Swelling or changes in blood pressure
Not every new symptom is caused by medication. The underlying illness or another health condition may be responsible.
It can be helpful to record:
- When the symptom began
- Whether a medicine was recently started or changed
- How severe the symptom is
- Whether it is improving or worsening
- Any other changes in health or treatment
These observations can help the clinical team decide whether further investigation or a treatment adjustment is needed.
Understanding Drug Interactions
Drug interactions are particularly important with azole antifungal medicines.
An interaction occurs when one medicine changes the effect, concentration or absorption of another medicine.
Some interactions can increase the risk of side effects. Others can reduce the effectiveness of treatment.
Important combinations may involve:
- Corticosteroids, including certain inhalers and nasal sprays
- Some medicines used for heart conditions
- Blood thinners
- Medicines that reduce stomach acid
- Immunosuppressive medicines
- Certain antibiotics and other antifungals
- Herbal remedies and supplements
For example, some acid-suppressing medicines can interfere with the absorption of certain itraconazole formulations. Other medicines may affect the way azole antifungals are broken down by the body.
Always check before adding or changing medicines. Patients should tell their pharmacist or prescribing clinician about all medicines they use, including those bought without a prescription.
Carers do not need to memorise every possible interaction. The most useful contribution is helping maintain a complete and accurate medication list.
How Carers Can Help Safely
Carers can provide valuable support without needing to become medication experts.
Keep an up-to-date medicine list
Include prescribed tablets, inhalers, nasal sprays, injections, creams, supplements and over-the-counter medicines.
Record the dose and timing where possible, and note any recent changes.
Help with appointments and monitoring
Keeping track of blood tests, clinic appointments and prescription renewals can reduce stress and help prevent missed monitoring.
Watch for changes
Carers may notice changes in mood, sleep, appetite, energy or general wellbeing that the patient has not recognised.
Recording these observations can make them easier to discuss with the clinical team.
Encourage questions
Useful questions for appointments include:
- What is this medicine intended to achieve?
- How long might it take to work?
- What monitoring is needed?
- Which side effects should we report?
- Are there medicines or supplements that should be avoided?
- What should we do if a dose is missed or the person cannot keep medicines down?
Missed-dose instructions differ between medicines, so it is best to follow the specific advice provided by the pharmacist or treating team rather than automatically doubling the next dose.
Respect the patient’s independence
Not everyone wants the same level of assistance. Discuss what help is welcome and involve the patient in decisions wherever possible.
When to Seek Medical Advice
Contact the treating team promptly if someone develops new or concerning symptoms after starting or changing treatment, particularly:
- A new or worsening rash
- Persistent vomiting or difficulty keeping medicines down
- Yellowing of the skin or eyes, dark urine or unusual abdominal pain
- New visual disturbances, dizziness or neurological symptoms
- Marked weakness, faintness or symptoms that could suggest a problem with steroid treatment
- Significant or unexplained deterioration in general health
When emergency help is needed
Call 999 in the UK if the person develops:
- Severe difficulty breathing
- Collapse or loss of consciousness
- Seizures
- Severe confusion or difficulty remaining awake
- Signs of a serious allergic reaction, such as swelling of the tongue or throat or breathing difficulty
People with known adrenal insufficiency should follow their emergency steroid plan and seek urgent medical help if an adrenal crisis is suspected. Persistent vomiting may prevent oral steroid replacement from being absorbed.
Do not stop or change prescribed treatment independently unless instructed by a healthcare professional or the person’s individual emergency plan.
Further Information
Managing medicines for aspergillosis can be complicated, especially when several treatments are being used together.
Carers can make an important contribution by helping with organisation, noticing possible side effects and supporting communication with healthcare professionals.
For more information, explore our Treatment of Aspergillosis guide.
Patients and carers can also join the National Aspergillosis Centre patient support meetings to share experiences and discuss practical challenges.
Remember: A treatment change does not always mean that the disease is getting worse. Sometimes it means the clinical team is finding a safer or more effective approach for the individual patient.
Author: Aspergillosis Patient Support Team
Editorial update: 19 October 2026
Next scheduled review: October 2028
This article provides general information and does not replace individual advice from a doctor or pharmacist. Clinical review attribution should reflect an actual completed review.
Did this page help you?
Tell us in one minute
